@inhibitortx.com
π’
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
PNG
About
Description
INHIBITOR Therapeutics, Inc. They specialize in developing and commercializing innovative therapies using already approved active pharmaceutical ingredients for novel, clinically valuable, and patent-protected indications. Their lead product is itraconazole, which is being developed to treat Gorlin's syndrome, a hereditary cancer syndrome categorized as an orphan disease.
Based in Tampa, FL, INHIBITOR Therapeutics is committed to providing groundbreaking solutions in the field of therapeutics. Their focus on utilizing existing active pharmaceutical ingredients ensures that patients can benefit from their innovative treatments as quickly as possible. With a strong dedication to research and development, INHIBITOR Therapeutics aims to transform the lives of those affected by cancer and other proliferation disorders.
Contact them today to learn more about their pipeline of cutting-edge therapies that are set to revolutionize treatment options
Company Type
Public Company
Company Size
2-10
Year Founded
2013
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere π
All services online
Top brand categories